NCT07416695 2026-02-18
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC
Shanghai Henlius Biotech
Phase 1 Not yet recruiting
Clinical Trials
9 trialsNCT06021483 2025-09-16
Observational Study to Evaluate the Safety and Efficacy of Zepzelcaâ„¢ Injection
Boryung Pharmaceutical Co., Ltd
Recruiting
NCT07145333 2025-09-08
Drug-SNP
Medicine Invention Design, Inc
Phase 2/3 Active not recruiting
NCT06179069 2025-08-15
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
Zai Lab (Hong Kong), Ltd.
Phase 1 Recruiting
NCT05844150 2025-03-12
A Study of PM8002 (Anti-PD-L1/VEGF) in Combination With Chemotherapy in Patients With ES-SCLC
Biotheus Inc.
Phase 2 Active not recruiting
NCT06616532 2024-12-19
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
Biotheus Inc.
Phase 3 Recruiting
NCT05879068 2024-12-18
A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC
Biotheus Inc.
Phase 2 Active not recruiting
NCT04750239 2023-08-14
Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer
Y-mAbs Therapeutics
Phase 1/2 Terminated
NCT05026593 2023-07-19
A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 1 Completed